PRKAR2B and prostate neoplasm: In detail, the expression of PRKAR2B was significantly increased in the prostate patients with hormone refractory (Figure 1A) [6], and elevated expression of PRKAR2B was also found in metastasized prostate tumors (Figure 1C–1D) compared to that in primary prostate tumors [7–9].